Guidance for industry : development and use of risk minimization action plans.

Bibliographic Details
Corporate Authors: Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.)
Format: Government Document eBook
Language:English
Published: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2005]
Subjects:
Online Access:https://purl.fdlp.gov/GPO/LPS116032
Description
Item Description:"Center for Biologics Evaluation and Research (CBER)".
"Clinical medical".
"March 2005".
Electronic resource.
Physical Description:1 online resource (23 pages).